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ABSTRACT
Dysfunctions of ubiquitin-proteasome system and toxicity of dopamine have been 
known as the key mechanisms in the pathogenesis of Parkinson’s disease (PD) and 
proteasome inhibitors are widely used in experimental models of PD to reproduce cell 
death of dopaminergic neurons. In the present study, immortalized human neural stem 
cells (HB1.F3, F3) and those transfected with human aromatic acid decarboxylase 
gene (F3.AADC), were used to investigate the mechanism of selective dopaminergic 
neuronal cell death mediated by dopamine or proteasome inhibitors. Flow cytometric 
analysis revealed that F3.AADC was more susceptible to dopamine than parental F3 
cell which does not carry dopaminergic phenotype. The dopamine-induced apoptosis 
was mediated by activation of caspases 3 and 9 and cleavage of PARP. Proteasome 
inhibitors also induced apoptosis in dose-dependent manner but there was no dif-
ference between cell types. Prolonged exposure to subtoxic dose of proteasome in-
hibitors further enhanced dopamine-induced apoptosis in the F3.AADC, and increased 
presence of alpha-synuclein and ubiquitin-positive inclusions was noted in the cyto-
plasm of apoptotic cells by immunocytochemistry. These findings indicate that dopa-
minergic cells are selectively susceptible to dopamine toxicity and prolonged suppres-
sion of proteasome system further enhances selective sensitivity to dopamine toxicity. 
Chronic subtoxic proteasomal dysfunction of dopaminergic cells might contribute to 
selective cell death of dopaminergic neurons during the pathogenesis of Parkinson's 
disease.
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INTRODUCTION
    Parkinson’s  disease  (PD)  is  one  of  the  most 
common neurodegenerative disorders, which is cha-
racterized  by  motor  symptoms,  such  as  brady-
kinesia,  rigidity,  tremor,  and  gait  disturbance.  PD 156 Sung-Man  Jeon,  et  al.
pathology  is  characterized  by  selective  dopaminer-
gic neuronal death and cytoplasmic Lewy bodies in 
substantia  nigra  of  midbrain  (Forno,  1996).  The 
cause  of  PD  is  yet  to  be  clarified  but  diverse 
genetic and environmental mechanisms are inferred 
(Weidong  et  al.,  2009). 
    Dopamine,  a  key  neurotransmitter  in  PD,  and 
L-DOPA, a precursor of dopamine cause cell death 
in  cultured  neural  cells  by  oxidative  and  non-
oxidative  mechanisms  (Ahmadi  et  al.,  2008).  In 
addition,  dopamine  turnover  is  increased  in  me-
sencephalic  dopaminergic  neurons  in  PD  patients 
and  reactive  oxygen  species  are  found  to  increase 
following  treatment  with  L-DOPA  (Foley  at  al., 
2000). However, there is no convincing evidence of 
neurotoxic  events  caused  by  dopamine  or  L-DOPA 
in  vivo  conditions. 
    The  ubiquitin-proteasome  system  is  known  to  be 
implicated  in  pathogenesis  of  PD.  Lewy  body,  a 
pathological  hallmark  of  Parkinson's  disease,  con-
tains  a  heterogeneous  mixture  of  proteins  and 
lipids,  including  alpha-synuclein,  ubiquitin,  synphi-
lin-1, neurofilaments, and oxidized proteins (Olanow 
and  McNaught,  2006).  Familial  PD  cases  are 
caused  by  abnormalities  in  genes  encoding  the 
proteins  alpha-synuclein,  parkin,  ubiquitin  carboxy- 
terminal  hydrolase-L1  and  DJ-1,  which  can  cause 
dysfunctions  of  proteasome  system  (Hatano  et  al., 
2009).  Proteasome  inhibitors  are  also  reported  to 
induce  neuronal  cells  hypersensitive  to  protein  al-
teration  or  oxidative  stress  (Mytilineou  et  al.,  2004; 
Rideout  et  al.,  2004;  Lev  et  al.,  2006).  Others  in 
contrast,  reported  that  proteasome  inhibitors,  such 
as lactacystin and MG-132, caused the appearance 
of  α-synuclein  and  ubiquitin  inclusions,  but  pre-
vented  dopaminergic  degeneration  in  a  6-hydroxy-
dopamine-induced  PD  animal  model  (Inden  et  al., 
2005).  To  date,  the  exact  role  of  proteasome 
inhibition  on  dopaminergic  neurodegeneration  and 
subsequent  development  of  Parkinson's  disease  is 
still  not  well  understood. 
    Human  neural  stem  cells  (NSCs)  could  serve  as 
a  good  in  vitro  model  system  representing  in  vivo 
conditions.  In  the  present  study,  immortalized  hu-
man neural stem cells (HB1.F3, F3) and those cells 
transduced with human aromatic acid decarboxylase 
gene  (F3.AADC),  were  used  to  investigate  the 
mechanism  of  selective  dopaminergic  neuronal  cell 
death  mediated  by  dopamine  or  proteasome  in-
hibitors.
MATERIALS  AND  METHODS
Cell  culture
    This study used human neural stem cells derived 
from  human  embryonic  telencephalon  (15  week  of 
gestational  age),  which  were  immortalized  by  using 
a  retroviral  vector  encoding  v-myc  oncogene  (Chu 
et al., 2003). One of the NSC clones, HB1.F3 (F3), 
expresses phenotypes specific for neural stem cells 
including  ABCG2,  nestin  and  mushashi-1  (Flax  et 
al.,  1998).  Additionally,  F3  expresses  Na
＋  current 
when  transduced  with  NeuroD  gene  and  differen-
tiated  into  neurons  (Cho  et  al.,  2002).  F3.AADC 
was  also  used  which  was  prepared  with  human 
aromatic  acid  decarboxylase  gene  transfection. 
Cells  were  cultured  in  the  Dulbecco’s  Modified 
Eagle  Medium  (DMEM,  Gibco-BRL,  Gathersberg, 
MD)  with  10%  fetal  bovine  serum.  L-DOPA  (5μM) 
were added to culture media of F3.AADC. Patterns 
of  growth  and  morphology  were  not  significantly 
different  from  those  of  non-transfected  or  supple-
mented  conditions. 
Measurement  of  dopamine
    The level of dopamine was measured in cells and 
cultured  media.  Medium  was  collected  after  2  days 
of culture, reacted with alumina (180 mg/ml, Sigma) 
in 4
oC for 24 hours, cleared with sample buffer (0.1 
M perchloric acid, 0.1 mM EDTA), and then filtered 
with  0.22μm  filter.  Cells  were  raked  out  from 
culture  dish  and  crushed  with  sample  buffer.  The 
supernatant  was  collected  after  centrifuge  and  fil-
tration.  Purified  cells  and  media  were  transferred 
through Reverse-Phase HPLC (Waters, Milford, MA) 
system in 0.5 ml/min mobile phase (0.07 M sodium 
phosphate  monobasic  pH  3.4,  1  mM  sodium  octa-
nesulfonic acid, 0.1 mM EDTA, 8% acetonitrile). We 
used HR-80 RP-C18 (Esa, Chelmsford, MA) column 
and  analyzed  with  Coulchem  II  electrochemical  de-
tector  (Esa,  Chelmsford,  MA)  in  400  mV. 
Measurement  of  cytotoxicity
    Cytotoxicity  was  evaluated  by  3,4,5-dimethyl  thi-
azole-3, 5-diphenyl tetrazolium bromide (MTT) assay 
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viable  cells  to  reduce  MTT  was  determined.  MTT 
stock  solution  (5  mg/ml)  was  prepared  in  PBS,  pH 
7.4,  filtered  through  0.22  M  filter  to  remove  for-
mazan  crystals  and  stored  at  −20
oC  in  the  dark. 
Cells were plated in a density of 5,000 cells/well on 
pre-coated  96-well  plates  and  incubated  for  in-
dicated  times.  Subsequently,  10-fold  diluted  MTT 
with  culture  medium  was  added  to  each  well  and 
incubated  for  4  hours.  Plates  were  centrifuged  at 
275×g  for  5  min  and  the  supernatant  was  as-
pirated.  The  formazan  crystals  were  completely 
dissolved  in  dimethyl  sulfoxide  by  vigorously  shak-
ing  on  microplate  shaker.  OD  was  read  on  micro-
plate  ELISA  reader  (El  312e,  Bio-Tek)  at  wave-
length  of  550  nm  and  630  nm.  Survival  of  each 
experimental  group  was  compared  with  that  of 
control  cells. 
Quantitative  assessment  of  apoptosis
    The quantification of apoptotic cells was screened 
by  flow  cytometry  technique  using  propidium  iodide 
(PI), identifying cells in late apoptosis of which high 
permeability  allows  PI  to  stain  intracellular  DNA 
(Tang  et  al.,  2005).  Cells  were  plated  in  a  6-well 
plate  and  incubated  for  different  time  points  with 
L-DOPA and dopamine, alone or in the presence of 
proteasome  inhibitors.  Cells  were  trypsinized  and 
washed  with  PBS  containing  1%  bovine  serum 
albumin.  Cells  were  fixed  with  70%  ethanol  con-
taining  0.5%  Tween  20  for  30  minutes  at  4°C  and 
stained  with  PBS  containing  0.5  mg/ml  of  PI  and 
1μg/ml  of  RNase  A.  Fluorescence  was  measured 
using  a  FACScan  cytometry  system  (Beckman 
Coulter  Epics  XL,  Palo  Alto,  CA).
    The  further  quantification  of  apoptotic  cells  was 
conducted  by  dual-color  flow  cytometry  technique 
using the annexin V conjugated with Alexa 488 and 
PI.  Annexin  V  detects  phosphatidylserine  in  the 
outer  membrane  leaflet,  a  marker  for  early  ap-
optosis, whereas PI identifies cells in late apoptosis 
(Behbahani  et  al.,  2005).  Cells  were  harvested, 
washed  in  PBS,  resuspended  in  100μl  of  Annexin 
binding  buffer  (10  mM  HEPES  pH  7.4,  140  mM 
NaCl,  2.5  mM  CaCl2)  and  treated  with  Alexa 
488-conjugated  annexin  V  (5μl)  and  PI  (5μg/ml). 
Cells  were  then  incubated  in  room  temperature  for 
15  minutes  and  analyzed  using  a  FACScan  cyto-
metry  system.
Measurement  of  mitochondrial  membrane  po-
tential  (MMP)
    Changes  in  MMP  after  treatments  with  L-DOPA 
and  dopamine,  alone  or  in  the  presence  of  pro-
teasome  inhibitors,  were  determined  by  staining 
cells  with  JC-1,  a  mitochondrial  potential  indicator 
dye.  JC-1  was  added  directly  to  the  cell  culture 
medium  (2μM)  and  incubated  for  30  minutes  at 
37
oC. After washing with culture medium, cells were 
trypsinized  and  resuspended  with  PBS.  Shift  from 
red  fluorescent  J-aggregates  into  green  JC-1  mo-
nomers  was  immediately  measured  by  flow  cyto-
metry.
Western  blot  analysis 
    For  antibody  cleavage  blots,  2×10
6  cells  treated 
for  the  indicated  time  points  with  L-DOPA  and 
dopamine,  alone  or  in  the  presence  of  proteasome 
inhibitors,  were  washed  twice  with  ice-cold  PBS, 
resuspended  in  500μl  of  ice-cold  modified  RIPA 
buffer  (1%  NP-40,  1%  sodium  deoxycholate,  0.1% 
SDS,  NaCl  150  mm,  25  mM  Tris-HEPES  pH  7.6). 
Cells  were  scraped  with  a  rubber  policeman,  and 
transferred  into  Eppendorf  tubes.  Cell  suspension 
was  rocked  on  a  rocker  at  4
oC  for  15  minutes  to 
lyse cells. The lysates were centrifuged at 14,000 g 
for 15 min at 4
oC. After protein quantification by the 
method  of  Bradford,  ∼20μg  of  proteins  per  well 
was  loaded  onto  8∼15%  SDS-polyacrylamide  gel 
electrophoresis.  The  gels  were  transferred  to  a 
polyvinylidene difluoride membrane (Amersham Bio-
sciences,  UK)  and  reacted  with  anti-PARP  (On-
cogene  Science,  Cambridge,  MA),  anti-caspase  3, 
and  anti-caspase  7  antibodies  (Santa  Cruz  Bio-
technology Inc, CA). Immunological complexes were 
revealed  with  the  appropriate  secondary  peroxi-
dase-coupled  antibodies  (Cell  Signaling  Technology 
Inc,  Danvers,  MA),  enhanced  chemiluminescence 
detection  system  (Amersham  Biosciences,  UK)  and 
detected  by  LAS-3000  (Fujifilm,  Tokyo,  Japan). 
Immunocytochemistry
    Cells  were  cultured  on  plastic  chamber  slides 
(Nunc,  Naperville,  IL),  treated  with  L-DOPA  and 
dopamine,  alone  or  in  the  presence  of  proteasome 
inhibitors,  and  fixed  with  4%  paraformaldehyde  at 
room  temperature  for  15  minutes.  After  washing, 
cells  were  permeabilized  with  phosphate-buffered 158 Sung-Man  Jeon,  et  al.
Fig.  1.  Dopamine-  and  L-DOPA-induced  cell  death.  Neural  stem  cells  were  incubated  with  various  concentrations  of  dopamine  (A)  and 
L-DOPA (B), and the total cell death after 24 hours was measured using MTT assay. Apoptosis was quantified by PI fluorescence using 
flow  cytometry. 
#p＜0.05,  vs.  control  condition,  *p＜0.05,  between  cell  lines.
saline  (137  mM  NaCl,  2.7  mM  KCl,  10  mM 
Na2HPO4, 2 mM KH2PO4 pH 7.4) containing 0.25% 
Triton  X-100  and  blocked  in  1%  bovine  serum 
albumin.  Primary  antibodies  against  α-synuclein 
(1：2,500, Sigma, St. Louis, MO) and ubiquitin (1：
500,  Chemicon,  Temecula,  CA)  were  incubated 
overnight  at  4
oC,  followed  by  secondary  antibodies 
conjugated  with  FITC  or  Texas  Red  (1：200, 
Molecular  Probe,  Eugene,  OR)  for  40  minutes  at 
room  temperature.  Hoechst  stain  was  used  to  ob-
serve  apoptosis.  The  slide  was  mounted  with  Vec-
tashield  mounting  media  containing  4,6-diamino-2- 
phenylindole  (Vetcor  Lab,  Burlingame,  CA),  and 
observed  under  the  confocal  microscope  (LSM510, 
Carl  Zeiss  GmbH.,  Jena,  Germany).
Statistical  analysis
    Data  analysis  was  performed  with  SPSS  18.0 
software  (SPSS Inc.,  Chicago,  IL).  The  significance 
of intergroup differences was evaluated by one-way 
analyses  of  variance  (ANOVA)  and  that  of  single 
comparisons  was  by  the  Student's  t-test.  Differ-
ences  were  considered  significant  at  p＜0.05.
RESULTS
Dopamine  production
    The basal levels of dopamine in cells and culture 
media  were  undetectable  in  human  neural  stem 
cells.  Addition  of  L-DOPA  to  F3.AADC  significantly 
increased  the  level  of  dopamine  in  culture  media, 
while  did  not  induce  any  noticeable  change  in  cell 
morphology or growth pattern as compared to those 
of parental F3 cells. The concentration of dopamine 
in  culture  media  was  0.9  ng/10
6  cells  in  F3  and 
14.6  ng/10
6  cells  in  F3.AADC.  Therefore,  F3.AADC 
can  be  regarded  as  dopamine-secreting  dopami-
nergic  cells  whereas  their  prototype  cells,  F3,  as 
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Fig.  2. D o p a m i n e -  a n d  L - D O P A - i n -
duced  apoptosis.  Neural  stem  cells 
were  incubated  with  dopamine  (500
μM )  o r  L - D O P A  ( 1 0 0 μM )  a n d  a p -
optotic cell death after 24 hours was 
quantified  by  Annexin  V  and  PI  flu-
orescence  using  flow  cytometry  (A) 
and nuclear Hoechst stain (B). Num-
bers  inside  the  boxes  of  L4  and  L2 
represent  percentages  of  cell  popu-
lation  in  early  and  late  stage  of  ap-
optosis,  respectively.
Cell  death  by  L-DOPA  and  dopamine
    Both  L-DOPA  and  dopamine  induced  cell  death 
in human neural stem cells was measured by either 
MTT  or  flow  cytometry  using  PI  assay.  Results  of 
cell  death  assessed  by  PI  assay  correlated  well 
with those using MTT assay, indicating that most of 
cell  death  induced  by  L-DOPA  or  dopamine  was 
apoptosis (Fig. 1). Dopamine-induced cell death was 
dose-dependent  and  more  prominent  in  F3.AADC 
than F3 cells (Fig. 1A). At 500μM of concentration, 
dopamine induced 42% of apoptotic cell death after 
24 hours in F3.AADC cells compared to 25% in F3 
cells (Fig. 1A). However, F3.AADC cells were more 
resistant  to  L-DOPA-induced  cell  death  than  to 
dopamine-induced  one  and  these  differences  were 
reached  statistical  significance  (Fig.  1B). 
Mode  of  L-DOPA  and  dopamine-induced  ap-
optosis
    To  elucidate  the  pathway  of  L-DOPA  or  dopa-
mine-induced  apoptotic  cell  death  in  dopaminergic 
cells  typical  apoptotic  markers  was  examined.  An-
nexin-V  assay  showed  that  both  L-DOPA  or  do-
pamine-induced  apoptosis  follows  typical  apoptotic 
steps  involving  early  apoptosis  with  translocation  of 
annexin V-positive phosphatidylserine to cell surface 
and  late  apoptosis  of  annexin  V-positive  and  PI- 
positive  fraction  (L4  and  L2  fraction,  respectively  in 
Fig.  2A).  Hoechst  stain  showed  increased  nuclear 
condensation  and  fragmentation  in  dopaminergic 
cells  by  both  L-DOPA  and  dopamine  (Fig.  2B). 
Measurement  of  mitochondrial  membrane  potential 
using  JC-1  showed  increased  shift  of  red  to  green 
fluorescence  after  8  hours  treatments  with  L-DOPA 
or  dopamine  in  dopaminergic  cells  (shifts  from  C2 
fraction  to  C4  fraction  in  Fig.  3A),  compared  to 
the  typical  orange-red  fluorescence  of  JC-1  ag-
gregates  in  F3  (C2  fraction  in  Fig.  3A).  L-DOPA 
and  dopamine-induced  apoptosis  caused  activation 
of  PARP,  caspase  3  and  caspase  7,  common 
execution  systems  in  apoptosis  by  western  blot 
analysis  (Fig.  3B).  These  findings  indicate  that 160 Sung-Man  Jeon,  et  al.
Fig. 3. Mitochondrial, PARP and cas-
pase-dependent  apoptosis  induced 
by  dopamine  and  L-DOPA.  Neural 
stem cells were incubated with dopa-
mine (500μM)  or  L-DOPA  (100μM) 
and  mitochondrial  membrane  poten-
tial  was  measured  by  flow  cytometry 
using JC-1 at 8 hours after treatment 
(A).  Activation  of  PARP,  caspase  3 
and  caspase  7  was  assessed  by 
western  blots  after  24  hours  of 
treatment  (B).
L-DOPA  and dopamine-induced  apoptosis follows a 
typical  mitochondrial  and  caspase-dependent  path-
way.
Apoptosis  by  proteasome  inhibitors
    Proteasome  inhibitors  induced  apoptosis  in  do-
paminergic  neurons  (Fig.  4).  PI  assay  showed  PSI 
was  more  potent  than  lactacystin  and  MG-132, 
inducing  over  40%  apoptosis  at  10  nM  in  all  the 
cell  types.  However,  there  was  no  significant 
difference  in  sensitivity  between  F3  and  F3.AADC. 
Effects of proteasome inhibition on dopamine- 
induced  apoptosis
    To  examine  the  combined  effect  of  proteasome 
inhibition  and  dopamine-induced  apoptosis,  F3  and 
F3.AADC  cells  were  simultaneously  treated  with 
dopamine and PSI or lactacystin for a short term at 
higher  concentrations  or  a  long  term  at  lower 
concentrations.  Both  proteasome  inhibitors  and 
dopamine induced apoptosis when treated alone for 
1  day,  as  shown  above  (Fig.  1B  and  4).  However, 
rate  of  apoptosis  following  combined  treatments 
was not increased additively when compared to that 
of dopamine or proteasome-only condition (Fig. 5A). 
And  when  treated  together  for  1  day  at  high 
concentration,  a  difference  in  dopamine  sensitivity 
between  F3  and  F3.AADC  was  not  observed  any 
more.  However,  long-term  culture  with  combined 
dopamine  and  low  concentration  of  proteasome 
inhibitors  (5  days)  significantly  increased  dopa-
mine-induced  apoptosis,  especially  in  F3.AADC 
cells,  making  dopaminergic  cells  more  sensitive  to 
dopamine  (Fig.  5B).
Inclusion  body  formation  in  the  process  of 
combined  dopamine  and  proteasome  inhibi-
tors-induced  apoptosis 
    Immunocytofluorescene  study  was  done  after 
long-term  culture  with  combined  dopamine  and  low 
concentration  of  proteasome  inhibitors  to  evaluate 
the correlation between formation of Lewy body-like 
cytoplasmic  inclusions  and  apoptosis  induced  by 
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Fig.  4.  Apoptosis  induced  by  proteasome  inhibition.  Neural  stem 
cells were incubated with indicated concentrations of proteasome 
inhibitor PSI (A), lactacystin (B) and MG-132 (C). Apoptosis was 
quantified  by  flow  cytometry  using  PI  at  24  hours  after 
treatments. There was no difference between cell lines. 
#p＜0.05, 
vs.  control  condition.
Fig.  5.  Effects  of  proteasome  inhibition  on  dopamine-induced 
apoptosis.  Neural  stem  cells  were  incubated  with  dopamine  in 
the  absence  or  presence  of  indicated  concentrations  of  pro-
teasome inhibitors, PSI and lactacystin, Apoptosis was quantified 
by flow cytometry using PI at 24 hours after treatments (A) or 5 
days  after  treatments  (B).  *p＜0.05,  vs.  without  dopamine, 
#p
＜0.05,  vs.  without  proteasome  inhibitors.
Apoptotic  cells  induced  by  long-term  treatment  of 
dopamine  alone  showed  increased  Lewy  body-like 
cytoplasmic  inclusions  containing  both  α-synuclein 
and  ubiquitin  (Fig.  6).  However,  α-synuclein  and 
ubiquitin  were  not  completely  co-localized  in  the 
same  Lewy  body-like  inclusions,  so  there  were 
some fractions of inclusions stained only with either 
α-synuclein  or  ubiquitin.  Addition  of  low  concen-
tration  of  proteasome  inhibitors  to  dopamine  further 
increased  α-synuclein  and  ubiquitin-positive  Lewy 
body  like  inclusions,  especially  in  the  F3.AADC. 
DISCUSSION
    Human  neural  stem  cells  (HB1.F3)  immortalized 
by  a  retroviral  vector  encoding  v-myc  were  em-
ployed  in  the  present  study.  Dopaminergic  trans-
formation  of  HB1.F3  was  carried  out  with  hu-
man  aromatic  acid  decarboxylase  gene  trans-
fection  (F3.AADC).  Addition  of  L-DOPA  into  culture 
media significantly increased the levels of dopamine 
in  cytoplasm  and  culture  media  of  F3.AADC,  com-
pared to those of F3 cells. Therefore F3.AADC cells 
were  regarded  as  dopaminergic  cell  line  producing 
dopamine  endogenously,  and  compared  with  non- 
secreting  F3  cells  to  evaluate  the  difference  in 
dopamine  sensitivity.
    Dopamine  and  L-DOPA-induced  cell  death  was 
found  in  a  dose-dependent  manner  in  all  cell  lines, 
and  dopaminergic  cell  lines  were  more  susceptible 
to  dopamine,  but  not  to  L-DOPA.  F3  was  more 
susceptible  to  L-DOPA,  which  might  be  explained 
by  a  preconditioning  effect  that  dopaminergic  cells 
were already exposed to L-DOPA as an additive to 
culture  media  or  endogenous  products.  Precon-
ditioning effect of reactive oxygen species (ROS) to 
protect  dopamine-induced  apoptosis  could  contri-
bute  the  susceptibility  of  F3  to  L-DOPA  (Tang  et 
al.,  2005). 
    Most  of  cell  death  induced  by  L-DOPA  or 
dopamine  was  apoptosis  as  shown  by  nuclear 
staining  with  PI  and  flow  cytometric  analysis  using 162 Sung-Man  Jeon,  et  al.
Fig.  6.  α-Synuclein  positive  inclu-
sion  body  formation  in  the  process 
of  apoptosis  induced  by  dopamine 
and  proteasome  inhibitors.  Neural 
stem  cells  were  treated  with  dopa-
mine  (50μM)  in  the  presence  or 
absence  of  proteasome  inhibitors, 
PSI  (1  nM)  and  lactacystin  (0.1μM) 
for  5  days.  Inclusion  body  forma-
tion  was  assessed  by  immunofluor-
escence study using α-synuclein (red) 
and  ubiquitin  (green).
annexin  V/PI.  Measurement  of  mitochondrial  mem-
brane potential showed increase of JC-1 monomeric 
form  in  dopaminergic  cells  by  dopamine.  These 
results  are  consistent  with  previous  studies  (Lee  et 
al.,  2007;  Zafar  et  al.,  2007),  indicating  that  dis-
ruption  of  mitochondrial  functions  had  a  role  in 
dopamine-induced  apoptosis  of  dopaminergic  cells. 
Caspases  play  an  important  role  in  the  apoptotic 
process  both  in  death  receptor  pathway  and  the 
mitochondrial pathway (Grütter, 2000). Western blot 
analysis  of  this  experiment  revealed  dopamine- 
induced  activation  of  caspase  3  and  7,  and  PARP 
in  the  course  of  apoptosis  in  dopaminergic  cells. 
    Proteasomes  are  the  primary  enzymes  involved 
in  the  degradation  of  proteins  within  cells.  Dys-
function of ubiquitin-proteasome system has taken a 
great  attention  in  the  pathogenesis  of  Parkinson's 
disease  (Olanow  and  McNaught,  2006).  In  the 
report  comparing  the  effect  of  dopamine  and 
proteasome  inhibitor,  dopamine-induced  neuronal 
death was blocked by anti-oxidants but the effect of 
proteasome inhibitor was not influenced, suggesting 
that  dopamine  induced  oxidative  cell  injury  but 
proteasome  inhibitor  could  contribute  to  cell  death 
by  non-oxidative  mechanism  (Zafar  et  al.,  2007). 
Several  proteasomal  inhibitors  have  been  used  as 
key  molecules  for  in  vivo  and/or  in  vitro  models  of 
Parkinson's disease. It has been demonstrated that 
MG132  induced  proteasomal  inhibition  with  ac-
cumulation of oxidized proteins and subsequent cell 
death  in  PC12  cells  and  N27  cells  (Sun  et  al., 
2006).  Lactacystin  has  been  documented  to  have 
the  capability  to  cause  impairment  of  ubiquitin- 
proteasome  system  and  sufficient  to  produce  cell 
death  in  cultured  dopaminergic  neuronal  cells 
(Reaney  et  al.,  2006).  PSI  has  drawn  a  great 
attention  because  of  the  recent  report,  which 
asserted  development  of  progressive  animal  model 
of  PD  by  systemic  exposure  of  PSI  (McNaught  et 
al.,  2004).  Nonetheless,  there  has  been  con-
siderable  debate  due  to  the  failure  of  replication  of 
this animal model (Kordower et al., 2006; Mathur et 
al.,  2007). 
    In  this  study,  proteasomal  inhibitors  induced 
dose-dependent  apoptosis,  and  there  was  no 
significant  difference  between  F3  and  dopaminergic 
cell  (F3.AADC).  Proteasomal  inhibition  further 
increased  dopamine-induced  apoptosis  in  time- 
dependent  manner.  Exposure  to  relatively  high 
concentration  of  proteasomal  inhibitors  for  short 
duration  (24  hours)  did  increase  apoptosis  in 
dopaminergic  cells  but  did  not  potentiate  the  effect 
of  dopamine-induced  apoptosis.  Chronic  exposure 
(5  days)  to  low  concentration  of  proteasomal 
inhibitors  significantly  increased  dopamine-induced 
apoptosis, especially in dopaminergic cells, resulting 
in  more  selective  dopamine  susceptibility.  Immu-
nostaining  with  α-synuclein  and  ubiquitin  showed 
formation  of  α-synuclein  and  ubiquitin-positive 
cytoplasmic  inclusion  bodies  in  the  process  of 
dopamine-induced  apoptosis  and  combination  with 
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increased inclusions, especially  in the dopaminergic 
cell  lines.  Recent  report  showed  time-dependent 
increase  of  cell  death  by  prolonged  exposure  to 
proteasome  inhibitors  with  corresponding  increase 
of  ROS  (Papa  et  al.,  2007).  Furthermore,  they 
suggested  ROS-dependent  collapse  of  the  mito-
chondrial  membrane  potential  and  the  nuclear  re-
localization  of  apoptosis-inducing  factor  were  de-
cisive  events  in  neuronal  cell  death,  independently 
on  caspase  mechanism.  Their  results  indicate  that 
chronic  exposure  to  subtoxic  dose  of  proteasome 
inhibitors  induces  neuronal  apoptosis  by  ROS, 
which  is  contradictory  to  those  of  Zafar  et  al. 
(2007). As previously cited, they found that subtoxic 
dose  of  proteasome  inhibitors  even  protect  6- 
hydroxy-dopamine-induced dopaminergic neural loss 
despite  increase  of  cytoplasmic  inclusions  sug-
gesting  a  protective  role  of  α-synuclein-positive 
inclusions (Inden et al., 2005). In the present study, 
which  was  consistent  with  those  of  Papa  et  al. 
(2007),  time-dependent  increase  of  cell  death  and 
potentiation  of  dopamine-induced  apoptosis  by 
proteasome  inhibitors  were  observed.  And  there 
were increased cytoplasmic inclusions in chronically 
proteasome  inhibitor-exposed  dopaminergic  cells. 
These findings could be another in vitro evidence to 
support PD animal model by chronic PSI exposure. 
However,  whether  the  mechanism  of  cell  death  by 
prolonged  exposure  to  proteasome  inhibitors  is 
different  from  that  by  acute  exposure  should  be 
further  elucidated. 
    In conclusion, dopaminergic cells (F3.AADC) were 
more  susceptible  to  dopamine  compared  to  pro-
totype  F3  neural  stem  cells.  Dopamine-induced 
apoptosis  was  through  activation  of  caspases  and 
disruption  of  mitochondrial  membrane  potential. 
Chronic  exposure  to  low  dose  proteasomal  in-
hibitors  further  increased  dopamine-induced  apop-
tosis  and  Lewy  body-like  cytoplasmic  inclusions 
selectively  in  dopaminergic  cells.  These  findings 
support that dopamine and proteasomal dysfunction 
play  important  roles  to  apoptotic  cell  death  of 
dopaminergic  neurons.  These  results  suggest  that 
chronic  proteasomal  dysfunction  superimposed  on 
dopamine  might  account  for  selective  dopaminergic 
neuronal  cell  death  in  the  pathogenesis  of 
Parkinson's  disease.
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